Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington’s Disease Patients—A Randomized Phase 2 Clinical TrialMichael Brownstein, Stephanie Lowenhaupt, Codrin Lungu et al.|Journal of Clinical Medicine|2020Cited by 32
Preface: promoting research in PLS: current knowledge and future challengesHiroshi Mitsumoto, David Marren, Martin R. Turner et al.|Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration|2020Cited by 15
Influence of Cooling duration on Efficacy in Cardiac Arrest Patients (ICECAP): study protocol for a multicenter, randomized, adaptive allocation clinical trial to identify the optimal duration of induced hypothermia for neuroprotection in comatose, adult survivors of after out-of-hospital cardiac arrestWilliam J. Meurer, Robert Silbergleit, Florian Schmitzberger et al.|Trials|2024Cited by 15
Influence of Cooling duration on Efficacy in Cardiac Arrest Patients (ICECAP): study protocol for a multicenter, randomized, adaptive allocation clinical trial to identify the optimal duration of induced hypothermia for neuroprotection in comatose, adult survivors of after out-of-hospital cardiac arrestWilliam J. Meurer, Robert Silbergleit, Florian Schmitzberger et al.|Research Square|2024Cited by 4